Primary Biliary Cholangitis Trial, Recruiting NCT02931513 Sponsor: University of Aarhus Condition: Primary Biliary Cholangitis
Back to Primary Biliary Cholangitis

Primary Biliary Cholangitis Trial, Recruiting

NCT02931513
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have recently been diagnosed with Primary Biliary Cholangitis (a liver condition)
  • You have not yet been treated with a medication called UDCA (ursodeoxycholic acid)

Who may not be able to join:

  • You are under 18 years of age
  • Your doctor expects you to live less than 6 months
  • You are expected to need a liver transplant within the next 6 months
  • You have liver cancer
  • You have cirrhosis (scarring of the liver) that is caused by something other than Primary Biliary Cholangitis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4522800676

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2016
Est. completion
1 January 2031

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

UDCA response (ALP <3 times upper normal limit, AST <2 times upper normal limit, and bilirubin ≤1 mg/dL after one year of treatment)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov